March 10, 2014

Although the United States is still waiting for final practical guidelines from the Food and Drug Administration about the launch of biosimilars and the standards required to meet the threshold of interchangeability, the rest of the world seems to be barreling forward with the development and launch of these important medicines.

March 7, 2014

Wegmans has expanded its pharmaceutical services to include the family pet, according a recent blog.

February 18, 2014

Actavis and Forest Labs. announced that they have entered into a definitive agreement under which Actavis will acquire Forest for a combination of cash and equity valued at approximately $25 billion, or $89.48 per Forest share ($26.04 in cash and 0.3306 Actavis shares for each share of Forest common stock).

February 18, 2014

McKesson and Rite Aid on Tuesday announced the signing of an expanded distribution agreement to include both brand and generic pharmaceuticals.

February 3, 2014

The Generic Pharmaceutical Association on Monday identified its key priorities for 2014 — guarding against confusion a proposed labeling change would cause; gaining access to biosimilar generics; and heralding the cost savings generated by generic utilization.

January 24, 2014

Hi-Tech Pharmacal Co., a specialty pharmaceuticals company, announced that it was granted final approval from the Food and Drug Administration for bromfenac ophthalmic solution 0.09% (once-a-day).

January 14, 2014

H.D. Smith celebrates 60 years of business in 2014, the wholesaler announced Monday.

January 9, 2014

A confluence of healthcare trends has expanded a lucrative, if challenging, opportunity for pharmacies able to invest in its potential.

December 17, 2013

Forty blockbuster drugs will use patent exclusivity in the United States between this year and 2020, according to a new study.

October 31, 2013

AmerisourceBergen announced on Thursday that fourth quarter revenue rose 28.3% as it gains “strong momentum” heading into fiscal 2014.

October 18, 2013

The Council for Responsible Nutrition, the dietary supplement industry’s leading trade association, earlier this week announced the addition of three new voting members, including Barrington Nutritionals, Stratum Nutrition and Vitatech Nutritional Sciences.

October 10, 2013

While the boom in generic drugs now looks set to wane, another segment of the pharmaceutical industry is rapidly rising and presenting new growth opportunities for pharmacy retailers: specialty drugs.

October 4, 2013

AmerisourceBergen on Friday announced the company will hold its annual manufacturer summit, ThinkLive 2013, Oct. 7 to 8 at the Fairmont Hotel in Dallas.

September 25, 2013

Looking into a company masquerading adulterated pharmaceuticals as miracle dietary supplements branded Reumofan, USA Today investigative journalists traveled as far as Mexico to find those responsible.

September 3, 2013

AmerisourceBergen and Walgreens on Tuesday officially launched the previously announced 10-year relationship to distribute pharmaceuticals to more than 8,100 Walgreens locations across the country.

August 12, 2013

The Drug Store News Group and Diplomat Specialty Pharmacy drew a packed room full of retail executives and pharmacy leaders from many of the nation’s top drug, supermarket and mass merchandise chains to a breakfast pow-wow Sunday morning in Las Vegas.

August 8, 2013

The National Association of Chain Drug Stores' Total Store Expo brings together vendors and retailers across the entire store — pharmacy, OTC, beauty, consumables and general merchandise — and the supply chain executives who get the goods to market. As the industry converges on Las Vegas for this game-changing show, DSN talks to four leading futurists about what the drug store of tomorrow will look like.

August 8, 2013

The urgency behind Diplomat's launch of its Retail Specialty Network isn't hard to fathom. As the growth momentum in pharmaceuticals shifts from traditionally developed drugs to more complex and expensive specialty and biotech products, traditional pharmacies without access to these specialized medicines — and the patients who depend on them — find themselves stranded in a receding market like boats at low tide.

July 30, 2013

Big data finds another application and another supporter. Sort of.

The full Senate will shortly take up a new track-and-trace bill (S. 959), which would establish a national system for tracking the pedigree and movement of most pharmaceuticals, from point of manufacture and distribution to the dispensing pharmacy and the patient at the end of the supply chain. The goal: to replace the hodge-podge of different state laws with a single, nationwide track-and-trace system capable of capturing the daily flood of drug production, distribution, dispensing and utilization data and channeling it into an accessible tool by which stakeholders and regulators could secure the pharmaceutical supply chain.

July 12, 2013

The creation of a clear approval pathway for biosimilar drugs remains a daunting task for the Food and Drug Administration, despite the fact that it's prescribed by law through the Patient Protection and Affordable Care Act. But when those lower-priced, generic versions of some staggeringly expensive bioengineered medicines do finally come to market, they're likely to have a profound effect on the nation's outlays for specialty pharmaceuticals.

July 2, 2013

Covidien has finished spinning off its pharmaceuticals division, the medical products maker said.

June 20, 2013

Tris Pharma has hired a former buyer from AmerisourceBergen to head its generic drug business, the company said.

April 26, 2013

Cardinal Health announced the renewal of its pharmaceutical distribution agreement with CVS Caremark to supply pharmaceuticals to the company’s retail pharmacies and distribution centers, as McKesson, which generally serves the PBM side of the business, also announced the renewal of its current distribution agreement with the pharmacy retailer.

The renewal of the agreements was not only critical for both companies but, as Adam Fein, president of Pembroke Consulting and CEO of Drug Channels Institute, wrote in his blog “CVS Caremark Renews with Cardinal and McKesson,” it also “demonstrates wholesalers' value in the brand-name pharmacy supply chain.”

April 25, 2013

Cardinal Health and McKesson separately announced the renewal of their pharmaceutical distribution agreements with CVS Caremark.